In this episode Sam speaks with Mike Zimmerman of Main Sequence Ventures, CSIRO's VC fund. Mike explains MSV's focus on commercialising world-class Australian deep science R&D.  Mike previews the remarkable companies and founders in next gen WiFi, cancer diagnosis, AI and Big Data already within the MSV portfolio and talks about why the fund is looking to Asia, and HK for additional investment. 

For more information about Main Sequence Ventures, please visit https://mseq.vc/